HP and hematoma: It has also been pointed out that the PPAR-γ agonist monascin increases the levels of haptoglobin (Hp) and CD163 on the surface of phagocytes in plasma, accelerating hematoma absorption through the Hp–Hb–CD163 pathway (1).